Likewise, studies of ND-gene mutations (such as ND6 13885insC) and OXPHOS upregulation in model systems demonstrate potential functional effects but lack evidence in large human metastatic CRC datasets to support the claim that these mutations drive metastasis rather than being passenger or adaptive events. This evidence concerns the gene NDP and colorectal carcinoma.